Please use this identifier to cite or link to this item:
|Title:||The Role of PET/CT in Radiotherapy Planning.||Austin Authors:||Lee, Sze Ting ;Scott, Andrew M||Affiliation:||Department of Nuclear Medicine & Centre for PET; Ludwig Institute for Cancer Research, Austin Health; Department of Medicine, University of Melbourne, Austin Health, Australia
|Issue Date:||16-Mar-2015||Publication information:||Current Radiopharmaceuticals; 8(1): 38-44||Abstract:||Positron Emission Tomography (PET) is increasingly being used in radiotherapy planning, with the development of hybrid imaging technology (PET/CT) allowing more accurate volumes being generated for external beam radiation treatment. This article will discuss the use of FDG PET in radiotherapy planning of various types of malignancies, as well as pitfalls and practicalities of integrating PET/CT in radiotherapy planning.||Gov't Doc #:||25808960||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12705||URL:||https://pubmed.ncbi.nlm.nih.gov/25808960||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.